Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing
- PMID: 29155856
- PMCID: PMC5695843
- DOI: 10.1371/journal.pone.0188154
Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing
Abstract
There is a significant clinical need to improve current therapeutic approaches to treat ocular surface injuries and disease, which affect hundreds of millions of people annually worldwide. The work presented here demonstrates that the presence of Silk-Derived Protein (SDP) on the healing rabbit corneal surface, administered in an eye drop formulation, corresponds with an enhanced epithelial wound healing profile. Rabbit corneas were denuded of their epithelial surface, and then treated for 72-hours with either PBS or PBS containing 5 or 20 mg/mL SDP in solution four times per day. Post-injury treatment with SDP formulations was found to accelerate the acute healing phase of the injured rabbit corneal epithelium. In addition, the use of SDP corresponded with an enhanced tissue healing profile through the formation of a multi-layered epithelial surface with increased tight junction formation. Additional biological effects were also revealed that included increased epithelial proliferation, and increased focal adhesion formation with a corresponding reduction in the presence of MMP-9 enzyme. These in vivo findings demonstrate for the first time that the presence of SDP on the injured ocular surface may aid to improve various steps of rabbit corneal wound healing, and provides evidence that SDP may have applicability as an ingredient in therapeutic ophthalmic formulations.
Conflict of interest statement
Figures




References
-
- Market Scope. (2016). Dry Eye Products Report: A Global Market Analysis for 2015 to 2021. https://market-scope.com [Accessed: 9Mar2017]
-
- Rhee D. & Pyfer M. The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease. (Lippincott Williams & Wilkins, 1999).
-
- Fraunfelder F. W. Corneal Toxicity From Topical Ocular and Systemic Medications. Cornea 25, 1133–1138 (2006). doi: 10.1097/01.ico.0000240084.27663.fd - DOI - PubMed
-
- Hopkinson A., McIntosh R., Tighe P., James D. & Dua H. Amniotic membrane for ocular surface reconstruction: donor variations and the effect of handling on TGF-{beta} content. IOVS 47, 4316–4322 (2006). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous